Marketing, Legal, and Business Issues Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

MARKETING, LEGAL, AND BUSINESS ISSUES

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.

Only $95.00

(Select Format)

This archive contains the following articles listed by volume, issue and page number:

Title (Click for Details)	Vol/Issue	Page

MARKETING RELATED ARTICLES
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy	Vol. 22 No. 6	471
Compounding from a Pharmacy Student's Perspective	Vol. 22 No. 4	281
Pharmacogenomics: Precision Pharmacy in 503A Compounding	Vol. 22 No. 2	95
Why Become Pharmacy Compounding Accreditation Board Accredited?	Vol. 20 No. 6	469
Bedside Manner: Not Just for Doctors Anymore	Vol. 19 No. 2	115
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists	Vol. 19 No. 1	14
Marketing: Using Facebook to Market Your Compounding Pharmacy	Vol. 18 No. 6	490
Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy	Vol. 18 No. 5	406
Marketing: Effective Use of Advertisements on Your Website	Vol. 18 No. 3	210
Effective Advertisements	Vol. 18 No. 2	120
Marketing	Vol. 18 No. 1	38
Marketing During the Holidays	Vol. 17 No. 6	482
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial	Vol. 17 No. 3	262
Marketing: Overcoming Objections to Prescribing Compounded Medications	Vol. 16 No. 6	484
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients	Vol. 16 No. 5	394
Okay, I've Got It: Now What Do I Do With It?	Vol. 16 No. 4	310
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy	Vol. 16 No. 3	224
Trade Shows: Planning Your Strategy	Vol. 16 No. 2	134
7 Marketing Tactics That Don't Work	Vol. 15 No. 5	388
7 Marketing Tactics That Don't Work, Part 3	Vol. 15 No. 4	320
7 Marketing Tactics That Don't Work, Part 2	Vol. 15 No. 3	222
Seven Marketing Tactics That Don't Work	Vol. 15 No. 2	130
Marketing Vitamins, Minerals, and Other Nutrients	Vol. 15 No. 1	44
Home Infusion Accreditation: Another Quality Recognition Branding Tool	Vol. 14 No. 5	360
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response	Vol. 14 No. 5	366
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging	Vol. 14 No. 1	26
Compounding Pharmacy: A Unique Service for a Unique Population	Vol. 14 No. 1	19
Marketing the Geriatric Patient	Vol. 13 No. 6	538
Marketing Veterinarians	Vol. 13 No. 5	410
An Abridged History of Aspirin	Vol. 13 No. 5	404
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study	Vol. 13 No. 5	440
Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing	Vol. 13 No. 4	311
PreScription: A Good Name: Pharmacy	Vol. 13 No. 3	180
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education	Vol. 13 No. 3	224
Blogging for Business	Vol. 13 No. 2	141
Technology for the Patient-Centric Pharmacy	Vol. 12 No. 5	434
Marketing: Taking Your Show on the Road	Vol. 12 No. 5	438
Branding: Give Your Small Business a Big Image	Vol. 12 No. 6	537
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization	Vol. 12 No. 4	334
Marketing for Your Community	Vol. 12 No. 4	338
Developing a Niche Marketing Strategy	Vol. 12 No. 3	242
Web 2.0 and Health 2.0: Are You In?	Vol. 12 No. 3	244
Newsletters: An Essential Marketing Tool	Vol. 12 No. 2	128
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care	Vol. 12 No. 2	174
Websites: Keeping Current in 2008	Vol. 12 No. 1	48
PostScription: Consumer Options for Disposal of Unused Medications	Vol. 12 No. 1	87
Standard Operating Procedure: Complaint and Mishap Rectification	Vol. 11 No. 5	414
Book Review: The Rexall Story: A History of Genius and Neglect	Vol. 11 No. 4	300
PostScription: IJPC—More Than a Journal	Vol. 11 No. 1	88
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists	Vol. 10 No. 6	462
PreScription: Certification and Accreditation	Vol. 10 No. 5	322
What are You Willing to Do?	Vol. 10 No. 4	287
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States	Vol. 10 No. 3	175
Quick Tips for Managing Market Directors	Vol. 10 No. 3	201
PreScription: The Squeaky Wheel Gets the Grease!	Vol. 10 No. 2	82
How'd They Do That?	Vol. 10 No. 1	46
Marketing Your Business for Success	Vol. 9 No. 6	445
What Customers Want	Vol. 9 No. 3	213
Communication Makes It or Breaks It	Vol. 9 No. 2	133
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime	Vol. 9 No. 1	37
PostScription	Vol. 8 No. 6	496
A Foot in the Door: Marketing Tips - Dealing With Personalities	Vol. 8 No. 5	373
Case Reports: Their Impact	Vol. 8 No. 4	266
A Foot in the Door: Building Relationships Builds Your Business	Vol. 8 No. 3	197
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.	Vol. 8 No. 2	107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation	Vol. 8 No. 2	113
Financially Speaking: Business Continuation Planning	Vol. 8 No. 2	120
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach	Vol. 8 No. 1	31
A Foot in the Door: Marketing Tips	Vol. 7 No. 6	454
How To Perform a Study in Your Pharmacy with Little or No Effort	Vol. 6 No. 3	186
Developing a Successful Compounding Business in a Small Town	Vol. 6 No. 2	108
A Guide to Effective Media Relations	Vol. 6 No. 2	111
High-tech Marketing Techniques	Vol. 5 No. 6	420
Formulations for Success, Part 2	Vol. 5 No. 4	287
Motivation and Management: How to Build Your Business into the Job You Love	Vol. 5 No. 3	166
Pricing Strategies	Vol. 5 No. 3	180
Pediatric Compounding: Coloring Outside the Lines	Vol. 5 No. 1	6
Marketing Your Prescription Compounding Practice: Part Three	Vol. 4 No. 3	199
Marketing Your Prescription Compounding Practice: Part Two	Vol. 4 No. 2	115
Marketing Your Prescription Compounding Practice: Part One	Vol. 4 No. 1	36
Marketing Tip: Marketing Reps Can Help	Vol. 4 No. 1	39
Marketing Tip: Flavors: Target Marketing to Doctors and Patients	Vol. 3 No. 6	454
Independent Pharmacists Score High with Consumers	Vol. 3 No. 6	457
Planning and Marketing a Natural HRT Patient Seminar	Vol. 3 No. 5	360
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars	Vol. 3 No. 5	362
Marketing Tip: PR Can Help with Image Change and Geographic Expansion	Vol. 3 No. 4	277
Marketing Tip: Teachable Moments: A Simple Concept	Vol. 3 No. 3	199
Marketing Tip: Locator Maps	Vol. 3 No. 2	127
HRT Marketing Tip	Vol. 3 No. 1	37
Essential Truths About HRT	Vol. 2 No. 1	10
Interview on HRT: Christiane Northrup, MD, FACOG	Vol. 2 No. 1	12
HRT and the Continuing Education of Health Care Professionals	Vol. 2 No. 1	18
Marketing to Veterinarians - Field Notes	Vol. 1 No. 4	236

Title (Click for Details)	Vol/Issue	Page

LEGAL RELATED ARTICLES
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2	Vol. 22 No. 6	475
PreScription: Updating Formulations	Vol. 22 No. 5	356
Current Trends and Emerging Priorities in Compounded Preparations for Children	Vol. 22 No. 5	358
Certification of Powder-containment Hoods for Nonsterile Compounding	Vol. 22 No. 5	369
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations	Vol. 22 No. 5	387
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1	Vol. 22 No. 5	401
Your Presence is Needed at Compounders on Capitol Hill!	Vol. 22 No. 3	204
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing	Vol. 22 No. 2	92
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management	Vol. 22 No. 2	108
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing	Vol. 22 No. 2	125
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy	Vol. 22 No. 2	129
PreScription: 2017--Some Good Things Happened and Some Others	Vol. 22 No. 1	4
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies	Vol. 22 No. 1	7
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives	Vol. 22 No. 1	26
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement	Vol. 21 No. 6	444
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!	Vol. 21 No. 6	468
Validation of the Technological Process of the Preparation "Milk by Vidal"	Vol. 21 No. 6	513
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Vol. 21 No. 5	356
Child-safety Containers/Devices and Compounding	Vol. 21 No. 5	364
Documentation: Records and Reports	Vol. 21 No. 5	373
IACP Legislative/Regulatory Update	Vol. 21 No. 5	382
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871	Vol. 21 No. 4	290
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives	Vol. 21 No. 3	180
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 21 No. 3	212
PreScription: Whatever Happened to Common Sense?	Vol. 21 No. 2	92
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Vol. 21 No. 2	95
The International Academy of Compounding Pharmacists Introduces a New President	Vol. 21 No. 2	116
Quality Control: (Material) Safety Data Sheets	Vol. 21 No. 2	118
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1	Vol. 21 No. 2	127
PreScription: Compounding Pharmacy Issues for 2017	Vol. 21 No. 1	4
When to Compound Medications for Veterinary Patients	Vol. 21 No. 1	19
Why You Should Become an International Academy of Compounding Pharmacists Member	Vol. 21 No. 1	28
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Vol. 20 No. 6	457
The "Lists": What Do They Mean?	Vol. 20 No. 6	477
Basics of Compounding: Clinical Pharmaceutics, Part 2	Vol. 20 No. 6	485
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals	Vol. 20 No. 5	356
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy	Vol. 20 No. 5	367
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!	Vol. 20 No. 5	377
Compounding Transdermal Medication for Feline Patients	Vol. 20 No. 4	271
IACP's 2016 Compounders on Capitol Hill Asks	Vol. 20 No. 4	294
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding	Vol. 20 No. 4	307
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Vol. 20 No. 4	351
PreScription: Patient Access to Pharmaceuticals	Vol. 20 No. 3	180
Compounding in Nigeria	Vol. 20 No. 3	189
IACP Names Voliva Executive Vice President	Vol. 20 No. 3	194
PreScription: Compounding: A Changing Paradigm	Vol. 20 No. 2	92
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations	Vol. 20 No. 2	95
Microbial Identification in Pharmaceutical Compounding	Vol. 20 No. 1	13
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success	Vol. 20 No. 1	29
PostScription: The Home Field Advantage	Vol. 20 No. 1	86
PreScription: The Documented Past and the Exciting Future	Vol. 19 No. 6	442
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance	Vol. 19 No. 6	449
Applying Quality of Design Concepts to Pharmacy Compounding	Vol. 19 No. 6	453
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Vol. 19 No. 6	487
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding	Vol. 19 No. 5	375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists	Vol. 19 No. 5	377
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1	Vol. 19 No. 5	389
PostScription: Progress Report: Provider Status Continues to Gain Strength!	Vol. 19 No. 5	437
PreScription: Potpourri of Opinions…From Many	Vol. 19 No. 4	266
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Vol. 19 No. 4	303
Basics of Compounding: The "Negative" List	Vol. 19 No. 4	311
IACP Says: "Fix DQSA"	Vol. 19 No. 3	212
Quality Assurance and Quality Control, Part 2	Vol. 19 No. 3	215
PostScription: Opportunities to Change the Pharmacy Landscape	Vol. 19 No. 3	271
New England Compounding Center Indictment	Vol. 19 No. 2	94
Standing Together Fixing the Drug Quality and Security Act	Vol. 19 No. 2	104
Standarized Compounding: The Importance of Doing it the Same Way Every Time	Vol. 19 No. 2	109
PreScription: 2014 in Review	Vol. 19 No. 1	4
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance	Vol. 19 No. 1	30
Basics of Sterile Compounding: Aseptic Processing	Vol. 19 No. 1	49
Basics of Compounding: The Revised "Not to Compound List"	Vol. 19 No. 1	57
PostScription: Pharmacists Advancing Toward Provider Status	Vol. 19 No. 1	86
Compounding Legislation: Focus Shifts to States	Vol. 18 No. 6	470
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future	Vol. 18 No. 6	526
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A	Vol. 18 No. 5	379
Compounding Practices in a Portuguese Community Pharmacy	Vol. 18 No. 5	392
PostScription: The Future of Veterinary Compounding	Vol. 18 No. 5	438
PreScription: Challenging Times	Vol. 18 No. 4	268
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety	Vol. 18 No. 4	270
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India	Vol. 18 No. 4	293
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill	Vol. 18 No. 4	302
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2	Vol. 18 No. 4	305
PreScription: Déjà Vu All Over Again	Vol. 18 No. 3	180
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter	Vol. 18 No. 3	208
PreScription: Standards vs Opinions	Vol. 18 No. 2	92
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective	Vol. 18 No. 2	101
Compounding Practices in Iran	Vol. 18 No. 2	112
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities	Vol. 18 No. 2	117
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year	Vol. 18 No. 1	4
Good Enough for America	Vol. 18 No. 1	20
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013	Vol. 18 No. 1	35
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding	Vol. 17 No. 6	477
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?	Vol. 17 No. 6	480
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety	Vol. 17 No. 6	485
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions	Vol. 17 No. 5	356
Compounding Pharmacies: Before and After an Inspection	Vol. 17 No. 5	358
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms	Vol. 17 No. 5	364
2013 State Compounding Legislation Tracker Updated: August 12, 2013	Vol. 17 No. 5	375
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters	Vol. 17 No. 5	439
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013	Vol. 17 No. 4	283
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover	Vol. 17 No. 4	290
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 17 No. 4	302
PostScription: Traditional vs Nontraditional Pharmacy	Vol. 17 No. 4	351
PreScription: Compounding for Drug Shortages	Vol. 17 No. 3	180
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists	Vol. 17 No. 3	182
Decontamination Technology: The Missing Element	Vol. 17 No. 3	193
International Academy of Compounding Pharmacists' Legislative/Regulatory Update	Vol. 17 No. 3	206
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations	Vol. 17 No. 3	210
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines	Vol. 17 No. 3	238
PreScription: Pharmacy Committees	Vol. 17 No. 2	92
Compounding in Ukraine	Vol. 17 No. 2	124
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 17 No. 2	128
PreScription: Looking for Solutions	Vol. 17 No. 1	4
Pediatric Health Care: An Introduction	Vol. 17 No. 1	6
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives	Vol. 17 No. 1	48
PostScription: GMPs and GCPs: A Topical Comparison	Vol. 17 No. 1	87
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act	Vol. 16 No. 6	446
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis	Vol. 16 No. 6	456
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 16 No. 6	476
Quality Control: Analytical Methods. Certificates of Analysis, Part 1	Vol. 16 No. 6	486
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel	Vol. 16 No. 6	490
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 16 No. 5	382
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers	Vol. 16 No. 4	294
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 16 No. 4	300
Selection of Color Additives: A Regulatory View	Vol. 16 No. 4	304
PreScription: You're On Your Own	Vol. 16 No. 3	180
PreScription: Working in Handcuffs	Vol. 16 No. 3	180
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 16 No. 3	220
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification	Vol. 16 No. 3	230
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy	Vol. 16 No. 2	94
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes	Vol. 16 No. 2	98
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone	Vol. 16 No. 1	86
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 16 No. 1	50
PreScription: Compounding: Keeping Elephants Our of Our Mouseholes	Vol. 15 No. 6	444
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 15 No. 6	471
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire	Vol. 15 No. 6	474
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse	Vol. 15 No. 6	526
PreScription: Third-party Inequities and Discrimination	Vol. 15 No. 5	356
Natural Tragedies: Planning for Disasters and Emergencies	Vol. 15 No. 5	368
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 15 No. 5	382
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2	Vol. 15 No. 5	408
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy	Vol. 15 No. 4	278
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 15 No. 4	286
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others	Vol. 15 No. 3	180
PreScription: Making Things Right--Or Not?	Vol. 15 No. 3	180
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists	Vol. 15 No. 3	218
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions	Vol. 15 No. 3	224
PreScription: Discontinued Drugs and Drug Shortages	Vol. 15 No. 2	92
PreScription: Compounding with Manufactured Products	Vol. 14 No. 6	448
Home Infusion: Overcoming the Barriers to Entry	Vol. 14 No. 6	450
PreScription: Compounding Veterinary Products: Needed but Problematic	Vol. 14 No. 5	358
Home Infusion Accreditation: Another Quality Recognition Branding Tool	Vol. 14 No. 5	360
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle	Vol. 14 No. 4	268
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals	Vol. 14 No. 4	268
PreScription: Healthcare Reform Is Not All That Is Happening in Washington	Vol. 14 No. 3	180
PostScription: Healthcare Reform and Compounding Issues	Vol. 14 No. 3	262
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs	Vol. 14 No. 2	131
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort?	Vol. 14 No. 2	174
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust	Vol. 13 No. 6	532
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding	Vol. 13 No. 6	525
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications	Vol. 13 No. 5	400
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction	Vol. 13 No. 5	447
PostScription: Compounding Pharmacy in Puerto Rico	Vol. 13 No. 4	350
PreScription: Electronic Prescribing	Vol. 13 No. 2	92
PostScription: Compounding in Argentina	Vol. 13 No. 2	175
PreScription: A New Start: What Will 2009 Bring?	Vol. 13 No. 1	4
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective	Vol. 13 No. 1	87
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs	Vol. 13 No. 1	56
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials	Vol. 13 No. 1	81
Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information	Vol. 12 No. 5	405
Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship	Vol. 12 No. 5	410
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers	Vol. 12 No. 5	414
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?	Vol. 12 No. 5	420
Prescription: Is "Globalization" a Good Idea?	Vol. 12 No. 6	474
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers	Vol. 12 No. 6	508
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where	Vol. 12 No. 6	514
PostScription: Supporting Compounding Around the World	Vol. 12 No. 6	565
PreScription: First Estriol, Then What?	Vol. 12 No. 4	284
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada	Vol. 12 No. 4	365
PostScription: It Is Not Just What You Say…But How You Say It!	Vol. 12 No. 4	375
Estriol: Women's Choice vs. A Manufacturer's Greed	Vol. 12 No. 4	286
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature	Vol. 12 No. 4	329
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization	Vol. 12 No. 4	334
PreScription: Pain!	Vol. 12 No. 3	180
Litigating the Legality of Compounding: The Medical Center Pharmacy Case	Vol. 12 No. 3	238
Current Compounding Practices in Europe	Vol. 12 No. 2	94
Compounding Around the World	Vol. 12 No. 2	102
Establishing a Quality-Assurance Program for Hospital Compounding	Vol. 12 No. 2	116
Hormone Therapy: It's Time for a Second Opinion	Vol. 12 No. 2	122
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care	Vol. 12 No. 2	174
PreScription: Year Number 12…And Still Much Work to Do	Vol. 12 No. 1	4
Disposing of Expired Drugs and Chemicals: New Options for Compounders	Vol. 12 No. 1	38
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996	Vol. 12 No. 1	63
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations	Vol. 12 No. 1	54
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists	Vol. 12 No. 1	74
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study	Vol. 11 No. 6	450
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds	Vol. 11 No. 6	487
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2	Vol. 11 No. 5	438
PreScription: Bias, NAMS, and HRT	Vol. 11 No. 4	266
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature	Vol. 11 No. 4	269
Premarin: The Intriguing History of a Controversial Drug	Vol. 11 No. 4	282
The Politics of Hormone Replacement Therapy	Vol. 11 No. 4	278
Quality-control Analytical Methods: Logbooks and Documentation Forms	Vol. 11 No. 4	306
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2	Vol. 11 No. 4	314
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration	Vol. 11 No. 4	326
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure	Vol. 11 No. 4	338
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1	Vol. 11 No. 4	350
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2	Vol. 11 No. 3	220
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1	Vol. 11 No. 3	230
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form	Vol. 11 No. 3	240
PostScription: Lobbying: How It Affects Compounding	Vol. 11 No. 3	262
PreScription: State or Federal Control of Pharmacy Practice	Vol. 11 No. 3	178
PreScription: Putting the Science Back into Pharmacy	Vol. 11 No. 2	92
Certified Diabetes Educator: A Credential for Compounding Pharmacists	Vol. 11 No. 2	112
Records and Record-Keeping for the Hospital Compounding Pharmacist	Vol. 11 No. 2	138
PreScription: IJPC: The Next 10 Years	Vol. 11 No. 1	2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1	Vol. 11 No. 1	5
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding	Vol. 11 No. 1	56
Pharmacogenomics: The End of Trial-and-Error Medicine?	Vol. 11 No. 1	59
PostScription: Challenges Facing an Analytical Laboratory	Vol. 10 No. 6	479
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists	Vol. 10 No. 6	462
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination	Vol. 10 No. 6	446
Topical Cidofovir for Treatment of Resistant Viral Infections	Vol. 10 No. 5	324
Education, Training, and Evaluation of Hospital Compounding Personnel	Vol. 10 No. 5	361
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction	Vol. 10 No. 5	377
PreScription: Standards, Legal Standards, and Accreditation	Vol. 10 No. 3	162
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate	Vol. 10 No. 3	165
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States	Vol. 10 No. 3	175
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?	Vol. 10 No. 3	202
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2	Vol. 10 No. 3	208
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!	Vol. 10 No. 3	240
PreScription: The Squeaky Wheel Gets the Grease!	Vol. 10 No. 2	82
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist	Vol. 10 No. 2	113
Pharmaceutical Legislation: An Historical Perspective	Vol. 10 No. 1	20
Pharmacy Compounding Urban Legends	Vol. 10 No. 1	32
Prescription: Pediatric Formulation Initiatives	Vol. 9 No. 6	410
Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America	Vol. 9 No. 5	332
Compounding: A Well-established Practice in 1938	Vol. 9 No. 5	364
Local Ventilation for Safe Containment in the Pharmaceutical Industry	Vol. 9 No. 4	293
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products	Vol. 9 No. 4	284
Survey of State Veterinary Compounding Laws and Regulations	Vol. 9 No. 3	209
PostScription: AVMA's Position on Compounding for Animals	Vol. 9 No. 3	247
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer	Vol. 9 No. 2	93
Standard Operating Procedure: SOP Master Book--Maintenance	Vol. 9 No. 2	145
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations	Vol. 9 No. 2	127
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations	Vol. 9 No. 2	136
PostScription: Experts Everywhere	Vol. 9 No. 2	167
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")	Vol. 9 No. 1	44
Is Veterinary Compounding Illegal Under Federal Law?	Vol. 8 No. 6	449
PostScription: Your voice is important to the future of pharmacy	Vol. 8 No. 5	407
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards	Vol. 8 No. 4	251
PostScription: Cleanroom Standards	Vol. 8 No. 2	160
PostScription: The Wedgewood Case: What It Means for Pharmacies	Vol. 8 No. 1	79
PreScription: Take Care with Terminology for Altered- and Slow-release Formulations	Vol. 7 No. 6	418
PostScription: Changing Pharmacy Regulations Could Affect US Compounders	Vol. 7 No. 6	495
Application of USP-NF Standards to Pharmacy Compounding	Vol. 7 No. 5	361
HIPAA Privacy and Security for Providers: The Basics	Vol. 7 No. 4	277
Containment of Hazardous Particulates in the Compounding Pharmacy	Vol. 7 No. 4	281
Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics?	Vol. 7 No. 4	320
Legal & Ethical Issues for Pharmacy Websites	Vol. 7 No. 2	88
Regulatory and Operational Issues of Founding a Compounding Pharmacy	Vol. 6 No. 6	434
Medications Discontinued in the United States	Vol. 6 No. 6	441
Compounding and the Courts	Vol. 6 No. 4	263
Facilities and Procedures for Compounding Hazardous Drugs	Vol. 6 No. 4	267
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer	Vol. 6 No. 4	271
Legal Issues: Technicians in the Compounding Pharmacy Practice	Vol. 6 No. 4	274
Medications Discontinued in the United States	Vol. 6 No. 4	286
Medications Discontinued in the United States	Vol. 6 No. 3	193
Medications Discontinued in the United States	Vol. 6 No. 2	123
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory	Vol. 6 No. 2	149
Compounding with Controlled Substances	Vol. 6 No. 1	8
The Problem of Drug Diversion	Vol. 6 No. 1	11
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective	Vol. 6 No. 1	13
PostScription: Regulatory Uncertainty Requires Professional Responsibility	Vol. 6 No. 1	80
Compounding Issues and Accreditation Agencies	Vol. 5 No. 4	273
The American Veterinary Medical Association Compounding Position Statement	Vol. 5 No. 3	216
Establishing and Maintaining a Compounding Pharmacy Reference Library	Vol. 5 No. 3	226
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding	Vol. 5 No. 2	97
Drugs Banned for Use in Food Animals: An Explanation	Vol. 5 No. 2	101
From Wagon-Era Paregoric to Computer-Era Herbals	Vol. 5 No. 2	112
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing	Vol. 5 No. 2	140
Assignment of a Beyond-Use Date for Compounded Preparations	Vol. 4 No .6	474
Compounding Using Hazardous Drugs	Vol. 4 No. 4	261
Compounding OTC Drugs: A Legal Perspective	Vol. 4 No. 3	180
Pharmacy Licensure Requirements	Vol. 4 No. 3	184
The Future of Compounding: An Industry Perspective	Vol. 4 No. 3	204
Assignment of Beyond-Use Dates	Vol. 4 No. 3	222
Analytical Testing of Extemporaneously Compounded Preparations	Vol. 4 No. 2	105
When Problem Audits Strike	Vol. 3 No. 6	458
When is Compounding for Animals Legal?	Vol. 3 No. 3	188
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices	Vol. 3 No. 2	126
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns	Vol. 3 No. 1	25
Opioids for Noncancer Pain: From Controversy to Consensus	Vol. 2 No. 2	106
Firing an Employee - Without Getting Burned	Vol. 2 No. 2	130
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding	Vol. 1 No. 6	399
Aspirin in Chloroform (Chloroform Banned in US)	Vol. 1 No. 6	407
The Decision to Compound	Vol. 1 No. 2	71
The Compounding Pharmacist	Vol. 1 No. 2	73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies	Vol. 1 No. 2	75

Title (Click for Details)	Vol/Issue	Page

BUSINESS RELATED ARTICLES
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy	Vol. 22 No. 6	471
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1	Vol. 22 No. 5	401
Compounding from a Pharmacy Student's Perspective	Vol. 22 No. 4	281
Your Presence is Needed at Compounders on Capitol Hill!	Vol. 22 No. 3	204
Pharmacogenomics: Precision Pharmacy in 503A Compounding	Vol. 22 No. 2	95
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies	Vol. 22 No. 1	7
Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting	Vol. 21 No. 5	384
PreScription: Just Think About It!	Vol. 21 No. 4	268
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives	Vol. 21 No. 3	180
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 21 No. 3	212
PreScription: Compounding Pharmacy Issues for 2017	Vol. 21 No. 1	4
Why Become Pharmacy Compounding Accreditation Board Accredited?	Vol. 20 No. 6	469
Choosing a Vial Processing Line for Aseptic Compounding: Part 1	Vol. 20 No. 4	283
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding	Vol. 20 No. 4	307
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives	Vol. 20 No. 2	114
PostScription: The Home Field Advantage	Vol. 20 No. 1	86
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States	Vol. 19 No. 6	514
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding	Vol. 19 No. 5	375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists	Vol. 19 No. 5	377
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists	Vol. 19 No. 1	14
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous	Vol. 18 No. 6	486
PreScription: Challenging Times	Vol. 18 No. 4	268
Effective Advertisements	Vol. 18 No. 2	120
Marketing	Vol. 18 No. 1	38
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services	Vol. 18 No. 1	87
Compounding Pharmacies: Before and After an Inspection	Vol. 17 No. 5	358
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach	Vol. 17 No. 5	393
Patient-centered Care as Value-added Service by Compounding Pharmacists	Vol. 17 No. 4	339
PreScription: Compounding for Drug Shortages	Vol. 17 No. 3	180
Optimizing Third-party Reimbursement for Compounded Medications	Vol. 17 No. 3	201
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial	Vol. 17 No. 3	262
PreScription: Pharmacy Committees	Vol. 17 No. 2	92
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel	Vol. 16 No. 6	490
Okay, I've Got It: Now What Do I Do With It?	Vol. 16 No. 4	310
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy	Vol. 16 No. 3	224
Trade Shows: Planning Your Strategy	Vol. 16 No. 2	134
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need	Vol. 15 No. 6	480
PreScription: Third-party Inequities and Discrimination	Vol. 15 No. 5	356
7 Marketing Tactics That Don't Work	Vol. 15 No. 5	388
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others	Vol. 15 No. 3	180
PreScription: Making Things Right--Or Not?	Vol. 15 No. 3	180
Seven Marketing Tactics That Don't Work	Vol. 15 No. 2	130
Home Infusion 101	Vol. 15 No. 1	6
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management	Vol. 15 No. 1	20
PostScription: Profile of a Pharmacy Compounding Accreditation Board–Accredited Pharmacy: Vital Care of Meridian	Vol. 15 No. 1	86
Home Infusion: Overcoming the Barriers to Entry	Vol. 14 No. 6	450
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy	Vol. 14 No. 6	531
Quality Control Analytical Methods: Continuous Quality Improvement	Vol. 14 No. 3	218
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network	Vol. 14 No. 2	134
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes	Vol. 14 No. 2	124
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study	Vol. 13 No. 5	440
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients	Vol. 13 No. 4	290
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care?	Vol. 13 No. 4	318
PostScription: Compounding in Israel	Vol. 13 No. 3	262
PreScription: A Good Name: Pharmacy	Vol. 13 No. 3	180
Tips for Cleanroom Construction and Renovation	Vol. 13 No. 2	100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations	Vol. 13 No. 2	106
Blogging for Business	Vol. 13 No. 2	141
Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy	Vol. 13 No. 2	138
Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys?	Vol. 13 No. 1	50
PreScription: Compounding Around the World	Vol. 12 No. 5	382
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers	Vol. 12 No. 5	414
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?	Vol. 12 No. 5	420
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations	Vol. 12 No. 5	432
Technology for the Patient-Centric Pharmacy	Vol. 12 No. 5	434
Prescription: Is "Globalization" a Good Idea?	Vol. 12 No. 6	474
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where	Vol. 12 No. 6	514
Branding: Give Your Small Business a Big Image	Vol. 12 No. 6	537
Web 2.0 and Health 2.0: Are You In?	Vol. 12 No. 3	244
Newsletters: An Essential Marketing Tool	Vol. 12 No. 2	128
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care	Vol. 12 No. 2	174
Websites: Keeping Current in 2008	Vol. 12 No. 1	48
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996	Vol. 12 No. 1	63
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists	Vol. 12 No. 1	74
The Internet and Its Websites: Your New Business Partner	Vol. 11 No. 6	472
The Whales: A Pharmacist's Story	Vol. 11 No. 5	376
Standard Operating Procedure: Complaint and Mishap Rectification	Vol. 11 No. 5	414
Premarin: The Intriguing History of a Controversial Drug	Vol. 11 No. 4	282
Book Review: The Rexall Story: A History of Genius and Neglect	Vol. 11 No. 4	300
The Politics of Hormone Replacement Therapy	Vol. 11 No. 4	278
Records and Record-Keeping for the Hospital Compounding Pharmacist	Vol. 11 No. 2	138
Information Resources and Software for the Hospital Compounding Pharmacist	Vol. 11 No. 1	36
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection	Vol. 11 No. 1	50
Compounding In Crisis:The Aftermath of Hurricane Katrina	Vol. 11 No. 1	28
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding	Vol. 11 No. 1	56
Calculations	Vol. 11 No. 1	68
PostScription: IJPC—More Than a Journal	Vol. 11 No. 1	88
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists	Vol. 10 No. 6	462
Education, Training, and Evaluation of Hospital Compounding Personnel	Vol. 10 No. 5	361
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction	Vol. 10 No. 5	377
What are You Willing to Do?	Vol. 10 No. 4	287
Quick Tips for Managing Market Directors	Vol. 10 No. 3	201
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!	Vol. 10 No. 3	240
PreScription: The Squeaky Wheel Gets the Grease!	Vol. 10 No. 2	82
How'd They Do That?	Vol. 10 No. 1	46
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success	Vol. 10 No. 1	50
Marketing Your Business for Success	Vol. 9 No. 6	445
Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success	Vol. 9 No. 6	452
Back to the Basics of Business	Vol. 9 No. 5	380
Standard Operating Procedure: Employee Personnel Records	Vol. 9 No. 4	309
Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation	Vol. 9 No. 3	173
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs	Vol. 9 No. 3	201
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer	Vol. 9 No. 2	93
Standard Operating Procedure: SOP Master Book--Maintenance	Vol. 9 No. 2	145
Communication Makes It or Breaks It	Vol. 9 No. 2	133
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime	Vol. 9 No. 1	37
Defining Success	Vol. 9 No. 1	42
Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't	Vol. 8 No. 6	412
A Foot in the Door: Marketing Tips - Dealing With Personalities	Vol. 8 No. 5	373
Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records	Vol. 8 No. 5	381
PostScription: Your voice is important to the future of pharmacy	Vol. 8 No. 5	407
PreScription - Categories of Pharmaceutial Compounding	Vol. 8 No. 4	242
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards	Vol. 8 No. 4	251
Rationale for a Pharmacists' Pharmacopeia	Vol. 8 No. 4	285
PostScription: What is Evidence-Based Medicine?	Vol. 8 No. 4	320
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor	Vol. 8 No. 3	162
Book and Literature Reviews	Vol. 8 No. 3	164
Compounding in the Pharmacy Curriculum: Beyond the Basics	Vol. 8 No. 3	181
Precepting: A Win-Win Situation for All	Vol. 8 No. 3	194
A Foot in the Door: Building Relationships Builds Your Business	Vol. 8 No. 3	197
Standard Operating Procedure: Disposal of Chemicals	Vol. 8 No. 3	210
Quality-Control Analytical Methods: High-Performance Liquid Chromatography	Vol. 8 No. 3	223
PostScription: How should a pharmacist be trained?	Vol. 8 No. 3	240
Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor	Vol. 8 No. 2	82
Literature Reviews	Vol. 8 No. 2	84
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists	Vol. 8 No. 2	89
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs	Vol. 8 No. 2	101
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.	Vol. 8 No. 2	107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation	Vol. 8 No. 2	113
Financially Speaking: Business Continuation Planning	Vol. 8 No. 2	120
Calibration/Validation of Incubator Temperature	Vol. 8 No. 2	130
Quality-Control Analytical Methods: Osmolality and Osmometry	Vol. 8 No. 2	143
PostScription: Cleanroom Standards	Vol. 8 No. 2	160
Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor	Vol. 8 No. 1	2
Book & Literature Reviews	Vol. 8 No. 1	4
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP	Vol. 8 No. 1	22
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach	Vol. 8 No. 1	31
Developing and Providing Compounding Services for Hospitals Involved in a Merger	Vol. 8 No. 1	36
American Pharmaceutical Patents From a Historical Perspective	Vol. 8 No. 1	40
Handling of Syringes and Needles	Vol. 8 No. 1	49
Quality-Control Analytical Methods: Selecting an Analytical Method	Vol. 8 No. 1	61
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy	Vol. 8 No. 1	65
Compounding for Investigational Studies: The Experience of Ken Hughes, RPh	Vol. 7 No. 6	436
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care	Vol. 7 No. 6	441
A Foot in the Door: Marketing Tips	Vol. 7 No. 6	454
Technology Spotlight: Automated Prescription-Dispensing Systems	Vol. 7 No. 6	458
PostScription: Changing Pharmacy Regulations Could Affect US Compounders	Vol. 7 No. 6	495
Book and Literature Reviews	Vol. 7 No. 5	324
Postcriptions: Compounding Paradox: Taught Less and Practiced More	Vol. 7 No. 5	399
Calculations	Vol. 7 No. 5	372
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices	Vol. 7 No. 5	401
Book Reviews	Vol. 7 No. 4	244
Literature Review	Vol. 7 No. 4	246
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT	Vol. 7 No. 4	258
HIPAA Privacy and Security for Providers: The Basics	Vol. 7 No. 4	277
Further Clarification of HIPAA Regulations	Vol. 7 No. 3	195
Software for the Compounding Pharmacist: An Update	Vol. 7 No. 3	197
Legal & Ethical Issues for Pharmacy Websites	Vol. 7 No. 2	88
Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon	Vol. 7 No. 2	101
Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy	Vol. 7 No. 2	118
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center	Vol. 7 No. 1	21
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2	Vol. 7 No. 1	32
Postcription: Future Trends in High Technology Pharmaceutical Compounding	Vol. 7 No. 1	80
The Cost of Quality in Pharmacy	Vol. 6 No. 6	404
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1	Vol. 6 No. 6	428
Regulatory and Operational Issues of Founding a Compounding Pharmacy	Vol. 6 No. 6	434
Medications Discontinued in the United States	Vol. 6 No. 6	441
Navigating New Territories in Compounding for Veterinary Medicine	Vol. 6 No. 5	324
Rites of Passage	Vol. 6 No. 5	337
Quality in Pharmacy: The New Zealand Experience	Vol. 6 No. 5	354
Third-Party Contracting for Compounding Pharmacies	Vol. 6 No. 5	359
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy	Vol. 6 No. 5	377
Establishing an Andropause Practice	Vol. 6 No. 4	259
Compounding and the Courts	Vol. 6 No. 4	263
Legal Issues: Technicians in the Compounding Pharmacy Practice	Vol. 6 No. 4	274
Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest	Vol. 6 No. 4	278
Magnetic Iron “Whiskers” in Cereals	Vol. 6 No. 4	281
Medications Discontinued in the United States	Vol. 6 No. 4	286
How To Perform a Study in Your Pharmacy with Little or No Effort	Vol. 6 No. 3	186
Medications Discontinued in the United States	Vol. 6 No. 3	193
pH and Osmolarity, A Review of	Vol. 6 No. 3	216
Developing Standard Operating Procedures	Vol. 6 No. 3	224
Developing a Successful Compounding Business in a Small Town	Vol. 6 No. 2	108
A Guide to Effective Media Relations	Vol. 6 No. 2	111
Medications Discontinued in the United States	Vol. 6 No. 2	123
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory	Vol. 6 No. 2	149
Compounding with Controlled Substances	Vol. 6 No. 1	8
The Problem of Drug Diversion	Vol. 6 No. 1	11
Team Building For Success	Vol. 6 No. 1	27
Safety for Employees in the Compounding Work Area	Vol. 6 No. 1	60
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit	Vol. 5 No. 6	412
High-tech Rx Compliance	Vol. 5 No. 6	419
High-tech Marketing Techniques	Vol. 5 No. 6	420
Training Personnel	Vol. 5 No. 6	474
Compounding Issues and Accreditation Agencies	Vol. 5 No. 4	273
Analytical Testing Facilities and Products	Vol. 5 No. 4	284
Formulations for Success, Part 2	Vol. 5 No. 4	287
Motivation and Management: How to Build Your Business into the Job You Love	Vol. 5 No. 3	166
A New Trend in Pharmacy Practice: Private Consultations	Vol. 5 No. 3	170
Formulations for Success in Compounding, Part 1	Vol. 5 No. 3	174
Developing a Business Plan for a Compounding Specialty Pharmacy	Vol. 5 No. 3	176
Pricing Strategies	Vol. 5 No. 3	180
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees	Vol. 5 No. 3	182
Book Reviews: Business Topics for Compounding Pharmacists	Vol. 5 No. 3	185
Software for the Compounding Pharmacist: A Review	Vol. 5 No. 3	187
Compounding in History: Compounding Economics	Vol. 5 No. 3	196
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective	Vol. 5 No. 3	221
Establishing and Maintaining a Compounding Pharmacy Reference Library	Vol. 5 No. 3	226
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy	Vol. 5 No. 2	118
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing	Vol. 5 No. 2	140
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding	Vol. 5 No. 2	147
Profile of a Practice	Vol. 5 No. 1	32
Sterile-Product Preparations: Mix or Buy?	Vol. 5 No. 1	59
On-Line Billing for Custom Compounds: The Third-Party Payor	Vol. 4 No .6	445
Profile of a Practice: Med Specialties Pharmacy	Vol. 4 No .6	448
Profile of A Practice: Hormone Replacement Therapy in the Heartland	Vol. 4 No. 5	362
Profile of a Practice	Vol. 4 No. 4	287
Pharmacy Licensure Requirements	Vol. 4 No. 3	184
Profile of a Practice: Surviving the Competition	Vol. 4 No. 3	203
The Future of Compounding: An Industry Perspective	Vol. 4 No. 3	204
Marketing Your Prescription Compounding Practice: Part Two	Vol. 4 No. 2	115
Profile of a Practice	Vol. 4 No. 2	120
Marketing Your Prescription Compounding Practice: Part One	Vol. 4 No. 1	36
Marketing Tip: Marketing Reps Can Help	Vol. 4 No. 1	39
Profile of a Practice	Vol. 4 No. 1	40
Calibration of Hot Plates	Vol. 4 No. 1	65
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care	Vol. 3 No. 6	455
Independent Pharmacists Score High with Consumers	Vol. 3 No. 6	457
When Problem Audits Strike	Vol. 3 No. 6	458
Finding the Balance	Vol. 3 No. 5	340
Compounding Practice Structures	Vol. 3 No. 5	368
Closing in on 2000: Your Y2K Report	Vol. 3 No. 5	371
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding	Vol. 3 No. 4	253
Profile of a Practice	Vol. 3 No. 4	288
Improving Profitability with Veterinary Compounding	Vol. 3 No. 3	180
Value and Pricing: Figuring Out What You're Worth	Vol. 3 No. 3	197
The BPS Pharmacy Specialty Certification Program	Vol. 3 No. 3	200
Profile of a Practice	Vol. 3 No. 2	116
Personal Computing: Take Care When Choosing a Computer Consultant	Vol. 3 No. 2	122
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices	Vol. 3 No. 2	126
Issues and Opportunities: Compounding for Dentistry	Vol. 3 No. 1	4
Audit Problems for Compounding Pharmacies	Vol. 3 No. 1	36
HRT Marketing Tip	Vol. 3 No. 1	37
Profile of a Practice	Vol. 3 No. 1	39
Physical Requirements for a Nuclear Pharmacy	Vol. 2 No. 6	426
Comparison of Job Satisfaction for Compounders and Noncompounders	Vol. 2 No. 6	455
Required Documentation for Home Infusion Pharmacies - Compounding Records	Vol. 2 No. 5	354
Third Party Contracts and the Compounding Pharmacy	Vol. 2 No. 4	286
A Glimpse Into the Future	Vol. 2 No. 3	203
An Eye to Success	Vol. 2 No. 3	205
Profile of a Practice: Office Practice Facilitates Compounding and Patient Counseling	Vol. 2 No. 3	219
Firing an Employee - Without Getting Burned	Vol. 2 No. 2	130
Problems with Third-Party Payments for Compounded Prescriptions	Vol. 2 No. 2	134
Hiring Good People	Vol. 2 No. 1	38
PostScription: Independent Pharmacy: Alive and Well	Vol. 2 No. 1	96
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding	Vol. 1 No. 6	399
What Makes Pharmacists Different?	Vol. 1 No. 4	214
Building a Compounding Lab: Remodeling an Existing Facility or Starting from Scratch?	Vol. 1 No. 3	156
Patient Handouts	Vol. 1 No. 3	160
PostScription: Growing the Tree of Pharmacy	Vol. 1 No. 2	136
The Decision to Compound	Vol. 1 No. 2	71
The Compounding Pharmacist	Vol. 1 No. 2	73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies	Vol. 1 No. 2	75
Hospice Care and the Pharmacist	Vol. 1 No. 1	11
The Ten Basic Steps in Filling a Prescription: Then and Now	Vol. 1 No. 1	14
An Ancient Heritage Beckons Pharmacists	Vol. 1 No. 1	22
Electronic Balance Maintenance/Calibration	Vol. 1 No. 1	45
General Guidelines for Use of Chemicals for Prescription Compounding	Vol. 1 No. 1	46
PostScription: The 90s Pharmacist	Vol. 1 No. 1	64

	Instant PDF Download
	Mailed CD